在帕金森病中,SNP与大脑结构和功能变化的计算关联
Swetha Subramaniyan1, Beena Briget Kuriakose2, Vijay Nattan1
1Department of Bioinformatics, Alagappa University, Karaikudi, Tamil Nadu, 630 003, India.
Neurogenetics
|August 9, 2025
概括
这项研究使用计算工具识别了帕金森病 (PD) 基因中的有害遗传变异. 一种FDA批准的药物对标蛋白具有很高的结合亲和力,为PD提供了潜在的治疗见解.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 计算生物学 计算生物学
背景情况:
- 帕金森病 (PD) 是一种流行的神经退行性疾病,全球发病率不断增加.
- 表观遗传因素和特定的基因 (SNCA,LRRK2,NURR1,ATP13A2,GSK3B,帕金,PINK1,DJ-1,UCHL1) 都与PD的发病有关.
- 识别有害的遗传变异对于了解PD进展至关重要.
研究的目的:
- 确定单核酸多态 (SNPs) 对九种关键的PD相关蛋白具有很高的有害作用.
- 通过对已识别的遗传变异进行FDA批准的药物的选来评估潜在的治疗策略.
主要方法:
- 利用超过13个计算工具对SNP进行序列,结构和功能分析.
- 使用了Frustrometer,NetSurf 3.0和xProtCAS服务器来选有害的SNP.
- 进行了蛋白质建模,结构和STRING分析,结合点分析,分子对接和分子动力学模拟.
主要成果:
- 在主要PD相关基因中确定了高度有害的误解变异.
- 一种FDA批准的药物在所有向突变蛋白中表现出高结合亲和力.
- 分子动力学模拟证实了该化合物的稳定性和与目标的相互作用.
结论:
- 这项研究为对导致帕金森病的遗传变异提供了新的见解.
- 已识别的药物化合物显示出作为PD潜在治疗剂的前景.
- 这些发现支持进一步研究PD治疗的个性化医疗方法.
更多相关视频
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
15.1K
09:06Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
Published on: June 9, 2018
12.2K
相关概念视频
01:37Neural Regulation
40.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.0K
01:15Parkinson's Disease: Overview
704
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
704
01:26Alzheimer's Disease: Overview
668
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
668